StayCurrentMD · Decreased β-catenin Protein in Lungs From Human Congenital Diaphragmatic Hernia Archival Pathology Specimens: A Case-control Study
Article1 min read·Published Feb 2024Older

Decreased β-catenin Protein in Lungs From Human Congenital Diaphragmatic Hernia Archival Pathology Specimens: A Case-control Study

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Feb 2024 · 1 min read

In brief

In brief

This case-control study investigates Wnt signaling pathway alterations in human CDH lungs by measuring beta-catenin protein levels in archival pathology specimens. While animal models show disrupted Wnt signaling in CDH-associated lung hypoplasia, human data remains limited, making this translational research critical for understanding CDH pathophysiology.

  • Lung hypoplasia is a major contributor to morbidity and mortality in congenital diaphragmatic hernia (CDH).
  • Wnt-signaling pathway and β-catenin (CTNNB1) alterations are documented in animal CDH models but poorly characterized in humans.
  • This study investigates whether Wnt-signaling gene expression is reduced in human CDH lungs compared to controls.
  • β-catenin acts as a transcription coactivator and may be a therapeutic target if dysregulated in human CDH.

Written by the GCMD Library team from the article.

Lung hypoplasia contributes to congenital diaphragmatic hernia (CDH) associated morbidity and mortality. Changes in lung wingless-type MMTV integration site family member (Wnt)-signalling and its downstream effector beta-catenin (CTNNB1), which acts as a transcription coactivator, exist in animal CDH models but are not well characterized in humans. We aim to identify changes to Wnt-signalling gene expression in human CDH lungs and hypothesize that pathway expression will be lower than controls.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →